In this episode I SHARE GOOD NEWS regarding vaginal estrogen use in breast cancer survivors, based on a new study from the March 2025 issue of the American Journal of Obstetrics and Gynecology. Common symptoms of urogenital atrophy, which results from estrogen loss and can be exacerbated by cancer treatments. The study reveals that low-dose vaginal estrogen does not increase breast cancer recurrence or mortality, offering solace to patients and physicians. I cannot stress importance of being informed, and being open discussions with your doctors. You must take charge and become and advocate for your own health.

00:00 Introduction to Gyno Info Frank Talk

00:53 Welcome and Overview of the Podcast

01:18 Personal Anecdote and Professional Commitment

02:48 Understanding Urogenital Atrophy

05:21 Causes and Symptoms of Estrogen Loss

07:21 Study on Vaginal Estrogen for Breast Cancer Survivors

10:23 Off-Label Use and FDA Guidelines

12:19 Conclusion and Listener Engagement

13:32 Final Thoughts and Contact Information

You can write to us at [email protected]

And follow us on Instagram @gynoinfo